MareaTX is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. The company leverages a proprietary drug discovery platform to identify and advance novel therapeutic candidates for conditions such as Alzheimer's disease.

We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives. THE THIRD ROCK TEAMOur team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed. A FORMULA FOR INNOVATION We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence.We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices and diagnostics. By creating value for patients, we create value for our investors.

Global Blood Therapeutics

Voyager Therapeutics

Larimar Therapeutics

Revolution Medicines

Rhythm Pharmaceuticals

SAGE Therapeutics

Bluebird Bio

Kala Pharmaceuticals

Nurix Therapeutics

Blueprint Medicines

Tango Therapeutics

Magenta Therapeutics

Thrive Earlier Detection

Constellation Pharmaceuticals

CytomX Therapeutics

Editas Medicine

Foundation Medicine

Fulcrum Therapeutics

Pliant Therapeutics

Relay Therapeutics

Third Rock Ventures

MareaTX

COM:MAREATX

MareaTX

Analysis Not Available